Surviving and thriving after a transplant

Explore a wealth of educational videos and practical tools

UK-DEF-2100028 l May 2021

Learn about best practice in severe VOD identification and treatment

Help patients survive and thrive after a transplant.

This treatment journey is designed by Jazz Pharmaceuticals for illustrative purposes.


Adverse events should be reported. Reporting forms and information for the UK can be found at:

For Ireland, reporting forms and information can be found at:

Adverse events should also be reported to Jazz Pharmaceuticals at:

Defitelio® is indicated for the treatment of severe hepatic veno-occlusive disease (VOD) also known as sinusoidal obstruction syndrome (SOS) in haematopoietic stem-cell transplantation (HSCT) therapy. It is indicated in adults and in adolescents, children and infants over 1 month of age.